THE Health Department has advised of an amended price for eribulin (Halaven) in the 01 Dec Schedule of Pharmaceutical Benefits, saying the dispensed price for items 10140Q and 11199K should be $853.74, not $1,492.56.
The above article was sent to subscribers in Pharmacy Daily's issue from 11 Dec 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 11 Dec 18